October 2025
1. FU Z, Li S, Xue J, Li Q, et al
   A potential therapeutic target at Connexin 43 serine phosphorylation against ischaemia/reperfusion arrhythmia.
   Br J Pharmacol. 2025;182:4516-4534.
   

   >> Share

   
   September 2025
2. HEITMANN S, Vandenberg JI, Hill AP
   Independent derivations of the axis of arrhythmia for predicting drug-induced torsades de pointes.
   Br J Pharmacol. 2025;182:4299-4313.
   

   >> Share

   
   March 2025
3. HINIESTO-INIGO I, Sridhar A, Louradour J, Cruz A, et al
   Rescue of loss-of-function long QT syndrome-associated mutations in K(V)7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S).
   Br J Pharmacol. 2025 Mar 14. doi: 10.1111/bph.70008.
   

   >> Share

   
   June 2024
4. NISKALA A, Heijman J, Dobrev D, Jespersen T, et al
   Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation.
   Br J Pharmacol. 2024 Jun 15. doi: 10.1111/bph.16470.
   

   >> Share

   
   April 2024
5. LEI CL, Whittaker DG, Mirams GR
   The impact of uncertainty in hERG binding mechanism on in silico predictions of drug-induced proarrhythmic risk.
   Br J Pharmacol. 2024;181:987-1004.
   

   >> Share

   
   February 2024
6. CHEN IS, Yasuda J, Notomi T, Nakamura TY, et al
   Licorice metabolite 18beta-glycyrrhetinic acid activates G protein-gated inwardly rectifying K(+) channels.
   Br J Pharmacol. 2024;181:447-463.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share